Open House Drug Discount Agreements Alitretinoin, ATC D11AH04

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 03, 2028 · 583 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Alitretinoin, ATC D11AH04

50/100

Score d'opportunité

Needs reviewLow complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

Automatic termination of the open-house agreement if a discount contract for the same active substance is awarded throu...

Missed monthly submission deadline may delay contract start by up to two months.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Moderate opportunity

Faits clés

Framework procurement
Supplies contract
1 lot
Duration until May 2028
Conclude non-exclusive discount agreements (Rabattverträge) for Alitretinoin (ATC D11AH04) under §130a Abs.8 SGB V.
Agreements are identical and non-negotiable; no selection or award procedure.

Afficher le résumé complet

Open-house model for non-exclusive discount agreements (Rabattverträge) on Alitretinoin (ATC D11AH04) by AOK Bayern. Any eligible pharmaceutical company can join at any time during the contract period (June 2026 – May 2028). No selection or price competition; only eligibility check. Final deadline for contract conclusion: 03.04.2028.

Risques

Automatic termination of the open-house agreement if a discount contract for the same active substance is awarded throu...

Missed monthly submission deadline may delay contract start by up to two months.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

Must be a pharmaceutical company.
Provide evidence of signing authority (trade register extract or power of attorney).

Administrative

Submit signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed self-declaration of reliability.

Acheteur

Nom

AOK Bayern - Die Gesundheitskasse

Localisation

München, DEU

[email protected]

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open House Drug Discount Agreements Alitretinoin, ATC D11AH04

Non-exclusive discount agreements with any eligible pharmaceutical company for the active substance Alitretinoin. Contract terms are identical and non-negotiable.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

May 2026 - May 2028

Catégorie

Pharmaceutical products

Date limite

Deadline Apr 03, 2028

Détails de la procédure

Date de publication: 14 Apr 2026
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 254716-2026

Documents (2)

Document de consultation 1 Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3